Immunic, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
IMUX on Nasdaq
Industry
Pharmaceutical Preparations
Location
1200 Avenue Of The Americas, Suite 200, New York, United States

Insiders trading volume in the past year

Immunic, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Daniel Vitt CEO and Director, Director $382K +$11.6K +3.12% Jul 16, 2025
Richard A. Rudick Director $161K +$100K +164% Jun 5, 2025
Joerg Neermann Director $152K +$76.7K +102% Jun 5, 2025
Glenn Whaley Chief Financial Officer $68.1K +$32.1K +89.1% Jul 16, 2025
Duane Nash Executive Chairman, Director $30.1K +$16.7K +125% Jul 16, 2025
Jason Tardio President and COO $9.88K +$9.88K Jul 16, 2025
Monika Maria Toernsen Director Jun 5, 2025
Andreas Muehler Chief Medical Officer Jul 16, 2025
Tamar Howson Director Jun 5, 2025
Barclay Phillips Director Jun 5, 2025
Jan van den Bossche Director Jun 15, 2022
Vincent Ossipow Director Jun 15, 2022
Simona Skerjanec Director Jun 5, 2025

Recent Insider Transactions by Companies or Individuals for Immunic, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.